asco 2021 - highlights on shifting parpi to early breast cancer: the olympia study
Published 3 years ago • 1.8K plays • Length 6:16Download video MP4
Download video MP3
Similar videos
-
5:49
perspectives on the olympia study of adjuvant olaparib in early breast cancer | nadine tung
-
10:04
asco 2021 highlights in breast cancer aditya bardia, md
-
2:44
olympia: adjuvant olaparib in gbrcam, her2-negative, high-risk, early breast cancer
-
7:11
asco daily news 2021 plenary update - lba1: olympia
-
29:27
highlights from the 2021 asco annual meeting, with lisa a. carey, md, fasco
-
28:03
highlights from asco 2021
-
27:48
asco 2021 clinical panel series - breast cancer
-
33:29
highlights on metastatic breast cancer & the asco/idea experience.
-
7:15
asco 2023 expert report in hr positive, her2 negative breast cancer by catherine harper-wynne
-
4:58
breast cancer highlights from the 2022 asco annual meeting | harold burstein
-
3:01
top news in breast cancer from asco 2021
-
1:04
highlights in breast cancer from esmo 2021
-
2:41
most anticipated data in the breast cancer space at asco 2021
-
5:00
olympia: adjuvant olaparib delays recurrence of brca-mutant breast cancer | judy garber
-
1:36
olympia trial
-
1:52
highlights from esmo breast cancer 2022
-
12:51
top 5 studies in breast cancer from asco 2021
-
1:16
breast cancer breakthroughs highlights from asco 2023: phergain trial
-
5:43
using olaparib in gbrca1/2 breast cancer